|
GB9622386D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
|
AU6279598A
(en)
|
1997-02-18 |
1998-09-08 |
Neurocrine Biosciences, Inc. |
Biazacyclic CRF antagonists
|
|
PL337888A1
(en)
|
1997-07-03 |
2000-09-11 |
Du Pont Pharm Co |
Imidazoprimidines and imidazopyridines for use in treating neurological disorders
|
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
|
US6124463A
(en)
*
|
1998-07-02 |
2000-09-26 |
Dupont Pharmaceuticals |
Benzimidazoles as corticotropin release factor antagonists
|
|
US6365589B1
(en)
*
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
|
US6271380B1
(en)
*
|
1998-12-30 |
2001-08-07 |
Dupont Pharmaceuticals Company |
1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
|
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
PL354784A1
(en)
|
1999-09-30 |
2004-02-23 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
EP1244666A1
(en)
|
1999-12-17 |
2002-10-02 |
Bristol-Myers Squibb Pharma Company |
Imidazopyrimidinyl and imidazopyridinyl derivatives
|
|
AU2001232271A1
(en)
*
|
2000-02-14 |
2001-08-20 |
Japan Tobacco Inc. |
Preventives/remedies for postoperative stress
|
|
KR20040034594A
(ko)
|
2001-01-26 |
2004-04-28 |
브리스톨-마이어스스퀴브컴파니 |
코르티코트로핀 방출 인자 억제제로서의 이미다졸릴 유도체
|
|
TWI312347B
(en)
*
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
WO2002076984A1
(en)
*
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
HUP0401292A3
(en)
|
2001-04-27 |
2011-01-28 |
Eisai R & D Man Co |
Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
|
|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
TWI283679B
(en)
|
2002-10-22 |
2007-07-11 |
Eisai Co Ltd |
7-phenylpyrazolopyridine compounds
|
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
|
MXPA05007485A
(es)
|
2003-01-14 |
2006-01-30 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
|
|
US7034023B2
(en)
*
|
2003-04-04 |
2006-04-25 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
GB0308208D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
US20070021429A1
(en)
*
|
2003-04-09 |
2007-01-25 |
Yves St-Denis |
Condensed n-heterocyclic compounds and their use as crf receptor antagonists
|
|
RS20060018A
(sr)
|
2003-07-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
|
|
US20060024661A1
(en)
*
|
2003-07-30 |
2006-02-02 |
The Regents Of The University Of California |
Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
|
|
EP1701961A1
(en)
|
2004-01-06 |
2006-09-20 |
Taisho Pharmaceutical Co., Ltd |
Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
|
|
CA2552503C
(en)
*
|
2004-01-06 |
2011-09-13 |
Taisho Pharmaceutical Co., Ltd. |
Pyrrolopyrimidine and pyrrolotriazine derivatives
|
|
JP2007530550A
(ja)
*
|
2004-03-26 |
2007-11-01 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物および方法
|
|
GB0428475D0
(en)
*
|
2004-12-30 |
2005-02-02 |
4 Aza Bioscience Nv |
Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
|
DE102005007160A1
(de)
*
|
2005-02-16 |
2006-08-24 |
Basf Ag |
Pyrazolcarbonsäureanilide, Verfahren zu ihrer Herstellung und sie enthaltende Mittel zur Bekämpfung von Schadpilzen
|
|
AU2006261607A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis C.
|
|
US8338435B2
(en)
*
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
|
WO2008077650A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008077649A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
|
TW200840584A
(en)
*
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
EP2266990B1
(en)
|
2008-04-15 |
2012-09-26 |
Eisai R&D Management Co., Ltd. |
3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND
|
|
WO2009152584A1
(en)
*
|
2008-06-20 |
2009-12-23 |
Macquarie University |
Synthesis of ageladine a and analogs thereof
|
|
WO2010002998A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Gilead Sciences, Inc. |
2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
|
|
JP5693452B2
(ja)
*
|
2008-08-04 |
2015-04-01 |
シーエイチディーアイ ファウンデーション，インコーポレーテッド |
特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法
|
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
|
KR101774035B1
(ko)
|
2009-10-30 |
2017-09-01 |
얀센 파마슈티카 엔.브이. |
이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
EP3323818A1
(en)
|
2010-09-22 |
2018-05-23 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
CN102796133B
(zh)
*
|
2011-05-27 |
2015-05-20 |
北京大学 |
一种稀土铕配合物及其作为发光材料的应用
|
|
WO2013000924A1
(en)
|
2011-06-27 |
2013-01-03 |
Janssen Pharmaceutica Nv |
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
|
|
KR20140072037A
(ko)
*
|
2011-08-30 |
2014-06-12 |
씨에이치디아이 파운데이션, 인코포레이티드 |
키뉴레닌-3-모노옥시게나제 억제제, 약학적 조성물 및 이의 사용 방법
|
|
SI2750677T1
(sl)
|
2011-08-30 |
2017-10-30 |
Chdi Foundation, Inc. |
Inhibitorji kinurenin-3-monooksigenaze, farmacevtski sestavki in postopki njihove uporabe
|
|
WO2014001314A1
(en)
|
2012-06-26 |
2014-01-03 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
|
AU2013289284B2
(en)
|
2012-07-09 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
|
ES2687950T3
(es)
*
|
2013-07-23 |
2018-10-30 |
Bayer Cropscience Aktiengesellschaft |
Procedimiento mejorado para preparar bifenilanilidas y bifenilanilinas cloradas
|
|
AU2015289492B2
(en)
|
2014-07-17 |
2020-02-20 |
Chdi Foundation, Inc. |
Methods and compositions for treating HIV-related disorders
|
|
PL3242666T3
(pl)
|
2015-01-06 |
2025-02-17 |
Arena Pharmaceuticals, Inc. |
Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
|
|
BR112017027656B1
(pt)
|
2015-06-22 |
2023-12-05 |
Arena Pharmaceuticals, Inc. |
Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
|
|
US11485733B2
(en)
|
2017-06-30 |
2022-11-01 |
Bayer Animal Health Gmbh |
Azaquinoline derivatives
|
|
CA3102136A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
KR20210108367A
(ko)
|
2018-11-09 |
2021-09-02 |
비바체 테라퓨틱스, 인크. |
비시클릭 화합물
|
|
WO2020147705A1
(zh)
|
2019-01-14 |
2020-07-23 |
青岛清原化合物有限公司 |
4-吡啶基甲酰胺类化合物或其衍生物、制备方法、除草组合物和应用
|
|
MX2021012638A
(es)
|
2019-04-16 |
2022-01-04 |
Vivace Therapeutics Inc |
Compuestos biciclicos.
|
|
CN121693501A
(zh)
|
2023-08-09 |
2026-03-17 |
拜耳公司 |
作为新的杀菌剂的哒嗪-4-基噁二嗪
|